###begin article-title 0
Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
To investigate whether angiopoietin-2, von Willebrand factor (VWF) and angiopoietin-1 relate to surrogate indicators of vascular permeability, pulmonary dysfunction and intensive care unit (ICU) mortality throughout the course of septic shock.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 55 63 <span type="species:ncbi:9606">patients</span>
In 50 consecutive mechanically ventilated septic shock patients, plasma angiopoietin-2, VWF and angiopoietin-1 levels and fluid balance, partial pressure of oxygen/inspiratory oxygen fraction and the oxygenation index as indicators of vascular permeability and pulmonary dysfunction, respectively, were measured until day 28.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
Angiopoietin-2 positively related to the fluid balance and pulmonary dysfunction, was higher in non-survivors than in survivors and independently predicted non-survival throughout the course of septic shock. VWF inversely related to the fluid balance and pulmonary dysfunction throughout the course of septic shock, was comparable between survivors and non-survivors and predicted non-survival on day 0 only. Angiopoietin-1 positively related to pulmonary dysfunction throughout the course, but did not differ between survivors and non-survivors.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
In contrast to VWF, plasma angiopoietin-2 positively relates to fluid balance, pulmonary dysfunction and mortality throughout the course of septic shock, in line with a suggested mediator role of the protein.
###end p 8
###begin title 9
Electronic supplementary material
###end title 9
###begin p 10
The online version of this article (doi:10.1007/s00134-009-1560-y) contains supplementary material, which is available to authorized users.
###end p 10
###begin title 11
Keywords
###end title 11
###begin title 12
Introduction
###end title 12
###begin p 13
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1018 1020 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1266 1268 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1387 1388 1387 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 1389 1390 1389 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 1392 1393 1392 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 1395 1397 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1466 1468 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1470 1472 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 512 520 <span type="species:ncbi:9606">patients</span>
###xml 1134 1142 <span type="species:ncbi:9606">patients</span>
Excessive and sustained activation of the endothelium resulting in increased vascular permeability is a crucial process during sepsis [1, 2]. In the lung, the loss of plasma fluid into the interstitial space leads to pulmonary oedema, injury and dysfunction associated with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) [1, 3]. Several clinical studies demonstrated that circulating levels of angiopoietin-2 (Ang-2) are elevated at the onset of critical illness in septic and non-septic patients with or at risk for ALI/ARDS, relate to vascular permeability and pulmonary dysfunction and are associated with intensive care unit (ICU) mortality [4-12]. It is not surprising that Ang-2 is a marker of those processes, since pre-formed Ang-2 can be released from the endothelial Weibel-Palade bodies during endothelial activation [13]. Another well-known marker of endothelial activation and dysfunction is von Willebrand factor (VWF), which is a major constituent of the Weibel-Palade body [13, 14]. We previously showed that Ang-2 and VWF levels are simultaneously enhanced in the plasma of ALI/ARDS or sepsis patients on admission to the ICU or onset of sepsis, suggesting that they are released together upon activation of the endothelium [12]. This may explain why both Ang-2 and VWF levels are associated with vascular permeability and pulmonary dysfunction [4-6, 8, 11, 12], even though VWF may not be directly involved in permeability [15, 16].
###end p 13
###begin p 14
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1209 1210 1209 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 1293 1294 1293 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 849 857 <span type="species:ncbi:9606">patients</span>
###xml 1179 1187 <span type="species:ncbi:9606">patients</span>
###xml 1283 1291 <span type="species:ncbi:9606">patients</span>
Experimental studies demonstrated that angiopoietin-1 (Ang-1) and Ang-2 bind to the endothelial Tie2 receptor [17-19]. Ang-1-induced activation of the Tie2 receptor results in vascular stabilisation [20-22]. Ang-2 provokes pulmonary inflammation and vascular leakage partly because of inhibition of the stabilising effect of Ang-1 by preventing Ang-1 from binding the Tie2 receptor [4, 5, 8, 10-12, 23, 24]. These experimental data together with clinical observations [4, 6, 7, 9, 11, 12] suggest that Ang-2 is not only a marker, but also a direct mediator in the pathogenesis of vascular permeability, pulmonary injury and dysfunction. This idea would be further reinforced if the relation between Ang-2, vascular permeability and pulmonary dysfunction persists throughout the course of critical illness in a homogeneous population of septic shock patients, more than VWF and Ang-1 levels. Up till now, the course and clinical correlates of Ang-2 have not been studied, and the predictive value of changes in Ang-2 during the course of septic shock for mortality is unknown. It has been hypothesised that the levels typically decrease in septic survivors and increase in septic patients that do not survive [5]. Only one study reported on the course of Ang-2 levels in multi-trauma patients [9], but clinical correlates were not studied.
###end p 14
###begin p 15
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 554 555 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 555 556 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 557 558 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 560 561 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 562 563 562 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
The aims of our study were (1) to investigate whether Ang-2, VWF and Ang-1 relate to surrogate indicators of vascular permeability and pulmonary dysfunction throughout the course of septic shock and (2) to study the course of Ang-2, VWF and Ang-1 levels in survivors and non-survivors and their predictive value for ICU mortality. Therefore, we measured plasma levels of Ang-2, VWF and Ang-1, and recorded fluid balance as surrogate indicator of vascular permeability [25-28] and partial pressure of oxygen in arterial blood/inspiratory oxygen fraction (PaO2/FiO2), oxygenation index [29], pulmonary compliance and ventilator-dependency [30] as surrogate indicators of pulmonary dysfunction, respectively, throughout the course of septic shock.
###end p 15
###begin title 16
Materials and methods
###end title 16
###begin p 17
###xml 574 575 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 596 597 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 599 600 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 661 662 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 740 742 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 899 901 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 1117 1119 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 1588 1589 1582 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 1589 1590 1583 1584 <sub xmlns:xlink="http://www.w3.org/1999/xlink">t</sub>
###xml 1653 1654 1647 1648 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1697 1698 1691 1692 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1718 1719 1712 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1719 1720 1713 1714 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1721 1722 1715 1716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1784 1785 1778 1779 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1848 1849 1842 1843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1849 1850 1843 1844 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 1851 1852 1845 1846 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2207 2208 2201 2202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 1312 1320 <span type="species:ncbi:9606">Patients</span>
###xml 1508 1516 <span type="species:ncbi:9606">Patients</span>
###xml 1865 1873 <span type="species:ncbi:9606">Patients</span>
###xml 2016 2024 <span type="species:ncbi:9606">Patients</span>
The local ethics committee approved this observational study and waived the need for informed consent. Fifty consecutive mechanically ventilated critically ill patients with community or ICU-acquired septic shock admitted to the ICU of the Radboud University Medical Centre (Nijmegen, The Netherlands) between January 2005 and September 2007 were included within 12 h after meeting septic shock criteria. Sepsis was defined by two or more of the following: abnormal body temperature (<36 or >38.5degreesC), tachycardia (>90/min), tachypnea [>20/min or partial pressure of CO2 in arterial blood (PaCO2) <32 mmHg], abnormal white blood cell counts (<4 or >12 x 109/l) and a microbiologically proven or clinically evident source of infection [29]. Septic shock was defined as sepsis complicated by acute circulatory failure characterised by persistent arterial hypotension unexplained by other causes [31]. Hypotension was defined by systolic arterial pressure <90 mmHg or mean arterial pressure (MAP) <70 mmHg for at least 1 h despite adequate fluid resuscitation or requirement of vasopressor support to maintain MAP [31]. ICU-acquired sepsis was defined as sepsis developing after 2 days in the ICU. The origin of septic shock was defined by clinical signs and symptoms and positive local and/or blood cultures. Patients were pressure-controlled or volume-controlled (after surgery) ventilated with a Galileo (Hamilton Medical AG; Rhazuns, Switserland) or a Servo ventilator (Maquet, Inc.; Bridgewater, NJ). Patients with ALI/ARDS were pressure-controlled ventilated with a tidal volume (Vt) aiming not to exceed 8 ml/kg and resulting in an end-tidal CO2 concentration between 4 and 5%, using an O2-air mixture with a FiO2 of 40% and a positive end-expiratory pressure (PEEP) of 5 cmH2O (inspiration:expiration 1:2) or more, when needed, guided by PaO2 (>60 mmHg). Patients were followed until death or discharge from the hospital. The 28-day ICU mortality, total ICU mortality and hospital mortality were recorded. Patients were treated by intensive care physicians not involved in the study according to institutional guidelines. Platelets were infused when the platelet count had dropped below 10-20 x 109/l, possibly as a result of diffuse intravascular coagulation, and when there were foci with a bleeding tendency.
###end p 17
###begin p 18
###xml 327 329 321 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> P</italic>
###xml 329 330 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 331 332 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 336 338 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> P</italic>
###xml 338 339 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 341 342 335 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 425 426 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 426 427 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink">t</sub>
###xml 429 431 423 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> F</italic>
###xml 431 432 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 433 434 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 454 455 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 455 459 449 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink">plat</sub>
###xml 484 485 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 485 489 479 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mean</sub>
###xml 666 667 660 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 667 671 661 665 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mean</sub>
###xml 674 675 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 675 676 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 677 678 671 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 686 687 680 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 687 688 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 689 690 683 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 692 694 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 754 755 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 755 756 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink">t</sub>
###xml 920 921 914 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1010 1011 1004 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 1160 1162 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 1263 1265 1257 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> P</italic>
###xml 1265 1266 1259 1260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 1267 1268 1261 1262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1269 1270 1263 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1270 1271 1264 1265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1272 1273 1266 1267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1457 1459 1447 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 1662 1664 1652 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 1665 1667 1655 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 860 867 <span type="species:ncbi:9606">patient</span>
###xml 929 936 <span type="species:ncbi:9606">patient</span>
###xml 1099 1106 <span type="species:ncbi:9606">patient</span>
###xml 1181 1188 <span type="species:ncbi:9606">patient</span>
###xml 1633 1640 <span type="species:ncbi:9606">patient</span>
On the inclusion day (day 0), demographics and clinical data were recorded including the Acute Physiology and Chronic Health Evaluation (APACHE) II score. The number of failing organs was scored. On day 0, day 7 +/- 1 days, day 14 +/- 2 days and day 28 +/- 3 days, arterial blood samples were obtained for determinations of pH, PaO2 and PaCO2, white blood cell counts and creatinine. The respiratory frequency, tidal volume (Vt), FiO2, plateau pressure (Pplat), mean airway pressure (Pmean) and PEEP were taken from the ventilator. The oxygenation index, which is a measure of oxygenation impairment for the intensity of mechanical ventilation, was calculated from (Pmean x FiO2 x 100)/PaO2 [29]. Total respiratory dynamic compliance was calculated from Vt/(plateau pressure-PEEP). Ventilator-free days were defined as follows: ventilator-free days = 0 if the patient dies before ICU day 28; ventilator-free days = 28 - x if the patient is successfully weaned from mechanical ventilation within 28 days, where x is the number of days spent on mechanical ventilation; ventilator-free days = 0 if the patient requires mechanical ventilation for 28 days or more [30]. Days at which a patient was ventilator-dependent were recorded. ALI and ARDS were characterised by PaO2/FiO2 </=300 or </=200 mmHg, respectively, and absence of clinical evidence of left atrial hypertension and congestive heart failure, according to the American European Consensus Criteria [32]. Vasopressor/inotropic treatment and body temperature were recorded. The fluid balance was calculated by dividing total fluid input minus total fluid output by the pre-ICU patient weight in kilograms [25-28]. Circulating Ang-2, VWF and Ang-1 were measured as described in the electronic supplementary material (ESM). The statistical analysis is described in the ESM.
###end p 18
###begin title 19
Results
###end title 19
###begin title 20
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics
###end title 20
###begin p 21
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 679 686 679 686 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 686 757 686 757 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="22">Demographic and clinical characteristics of survivors and non-survivors</p>
###xml 686 757 686 757 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="22">Demographic and clinical characteristics of survivors and non-survivors</p></caption>
###xml 757 757 757 757 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 766 766 766 766 <break xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 757 774 757 774 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Survivors<break/>(<italic>n</italic>&#160;=&#160;35)</th>
###xml 787 787 787 787 <break xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 788 789 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 774 795 774 795 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Non-survivors<break/>(<italic>n</italic>&#160;=&#160;15)</th>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 795 802 795 802 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>P</italic> value</th>
###xml 757 802 757 802 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left">Survivors<break/>(<italic>n</italic>&#160;=&#160;35)</th><th align="left">Non-survivors<break/>(<italic>n</italic>&#160;=&#160;15)</th><th align="left"><italic>P</italic> value</th></tr>
###xml 757 802 757 802 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left">Survivors<break/>(<italic>n</italic>&#160;=&#160;35)</th><th align="left">Non-survivors<break/>(<italic>n</italic>&#160;=&#160;15)</th><th align="left"><italic>P</italic> value</th></tr></thead>
###xml 802 811 802 811 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age, year</td>
###xml 811 821 811 821 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">68 (21&#8211;87)</td>
###xml 821 832 821 832 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">65 (30&#8211;102)</td>
###xml 832 837 832 837 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.427</td>
###xml 802 837 802 837 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age, year</td><td char="(" align="char">68 (21&#8211;87)</td><td char="(" align="char">65 (30&#8211;102)</td><td char="." align="char">0.427</td></tr>
###xml 837 846 837 846 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sex, male</td>
###xml 846 853 846 853 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">21 (60)</td>
###xml 853 860 853 860 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (87)</td>
###xml 860 865 860 865 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.099</td>
###xml 837 865 837 865 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Sex, male</td><td char="(" align="char">21 (60)</td><td char="(" align="char">13 (87)</td><td char="." align="char">0.099</td></tr>
###xml 865 888 865 888 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Surgery prior to sepsis</td>
###xml 888 895 888 895 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">17 (49)</td>
###xml 895 901 895 901 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9 (60)</td>
###xml 901 906 901 906 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.459</td>
###xml 865 906 865 906 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Surgery prior to sepsis</td><td char="(" align="char">17 (49)</td><td char="(" align="char">9 (60)</td><td char="." align="char">0.459</td></tr>
###xml 906 922 906 922 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Source of sepsis</td>
###xml 922 922 922 922 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 922 922 922 922 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 922 927 922 927 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.529</td>
###xml 906 927 906 927 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Source of sepsis</td><td align="left"/><td align="left"/><td char="." align="char">0.529</td></tr>
###xml 927 937 927 937 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Pulmonary</td>
###xml 937 944 937 944 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15 (43)</td>
###xml 944 950 944 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9 (60)</td>
###xml 950 950 950 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 927 950 927 950 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Pulmonary</td><td char="(" align="char">15 (43)</td><td char="(" align="char">9 (60)</td><td align="left"/></tr>
###xml 950 960 950 960 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Abdominal</td>
###xml 960 967 960 967 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15 (43)</td>
###xml 967 973 967 973 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (33)</td>
###xml 973 973 973 973 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 950 973 950 973 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Abdominal</td><td char="(" align="char">15 (43)</td><td char="(" align="char">5 (33)</td><td align="left"/></tr>
###xml 973 984 973 984 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Urogenital</td>
###xml 984 989 984 989 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (3)</td>
###xml 989 990 989 990 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0</td>
###xml 990 990 990 990 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 973 990 973 990 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Urogenital</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr>
###xml 990 1005 990 1005 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Pressure sores</td>
###xml 1005 1010 1005 1010 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (3)</td>
###xml 1010 1011 1010 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0</td>
###xml 1011 1011 1011 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 990 1011 990 1011 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Pressure sores</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr>
###xml 1011 1019 1011 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Unknown</td>
###xml 1019 1025 1019 1025 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (14)</td>
###xml 1025 1031 1025 1031 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (13)</td>
###xml 1031 1031 1031 1031 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1011 1031 1011 1031 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Unknown</td><td char="(" align="char">5 (14)</td><td char="(" align="char">2 (13)</td><td align="left"/></tr>
###xml 1031 1046 1031 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Culture results</td>
###xml 1046 1046 1046 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1046 1046 1046 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1046 1051 1046 1051 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.241</td>
###xml 1031 1051 1031 1051 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Culture results</td><td align="left"/><td align="left"/><td char="." align="char">0.241</td></tr>
###xml 1051 1064 1051 1064 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Blood gram &#8722;</td>
###xml 1064 1069 1064 1069 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (6)</td>
###xml 1069 1074 1069 1074 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (7)</td>
###xml 1074 1074 1074 1074 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1051 1074 1051 1074 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Blood gram &#8722;</td><td char="(" align="char">2 (6)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr>
###xml 1074 1087 1074 1087 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Blood gram +</td>
###xml 1087 1088 1087 1088 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0</td>
###xml 1088 1094 1088 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (13)</td>
###xml 1094 1094 1094 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1074 1094 1074 1094 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Blood gram +</td><td char="(" align="char">0</td><td char="(" align="char">2 (13)</td><td align="left"/></tr>
###xml 1100 1101 1100 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1094 1108 1094 1108 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Local<sup>a</sup> gram &#8722;</td>
###xml 1108 1114 1108 1114 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (14)</td>
###xml 1114 1119 1114 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (9)</td>
###xml 1119 1119 1119 1119 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1094 1119 1094 1119 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Local<sup>a</sup> gram &#8722;</td><td char="(" align="char">5 (14)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr>
###xml 1125 1126 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1119 1133 1119 1133 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Local<sup>a</sup> gram +</td>
###xml 1133 1139 1133 1139 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (20)</td>
###xml 1139 1144 1139 1144 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (7)</td>
###xml 1144 1144 1144 1144 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1119 1144 1119 1144 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Local<sup>a</sup> gram +</td><td char="(" align="char">7 (20)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr>
###xml 1165 1166 1165 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 1144 1168 1144 1168 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Leukocytes day 0,&#160;&#215;10<sup>9</sup>/l</td>
###xml 1168 1183 1168 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11.9 (2.8&#8211;86.0)</td>
###xml 1183 1197 1183 1197 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2.7 (0.4&#8211;74.8)</td>
###xml 1197 1209 1197 1209 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.661, 0.209</td>
###xml 1144 1209 1144 1209 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Leukocytes day 0,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">11.9 (2.8&#8211;86.0)</td><td char="(" align="char">2.7 (0.4&#8211;74.8)</td><td char="." align="char">0.661, 0.209</td></tr>
###xml 1230 1231 1230 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 1209 1233 1209 1233 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Leukocytes day 7,&#160;&#215;10<sup>9</sup>/l</td>
###xml 1233 1248 1233 1248 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.6 (5.6&#8211;54.5)</td>
###xml 1248 1264 1248 1264 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11.3 (1.7&#8211;243.1)</td>
###xml 1264 1264 1264 1264 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1209 1264 1209 1264 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Leukocytes day 7,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">15.6 (5.6&#8211;54.5)</td><td char="(" align="char">11.3 (1.7&#8211;243.1)</td><td align="left"/></tr>
###xml 1286 1287 1286 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 1264 1289 1264 1289 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Leukocytes day 14,&#160;&#215;10<sup>9</sup>/l</td>
###xml 1289 1304 1289 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">12.8 (7.5&#8211;33.8)</td>
###xml 1304 1320 1304 1320 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">18.8 (4.1&#8211;101.0)</td>
###xml 1320 1320 1320 1320 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1264 1320 1264 1320 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Leukocytes day 14,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">12.8 (7.5&#8211;33.8)</td><td char="(" align="char">18.8 (4.1&#8211;101.0)</td><td align="left"/></tr>
###xml 1320 1347 1320 1341 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Temperature day 0, &#176;C</td>
###xml 1347 1363 1341 1357 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">37.7 (34.4&#8211;41.2)</td>
###xml 1363 1379 1357 1373 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">38.0 (34.3&#8211;40.4)</td>
###xml 1379 1391 1373 1385 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.288, 0.600</td>
###xml 1320 1391 1320 1385 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Temperature day 0, &#176;C</td><td char="(" align="char">37.7 (34.4&#8211;41.2)</td><td char="(" align="char">38.0 (34.3&#8211;40.4)</td><td char="." align="char">0.288, 0.600</td></tr>
###xml 1391 1418 1385 1406 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Temperature day 7, &#176;C</td>
###xml 1418 1434 1406 1422 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">37.5 (35.6&#8211;39.8)</td>
###xml 1434 1450 1422 1438 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">38.2 (34.0&#8211;40.0)</td>
###xml 1450 1450 1438 1438 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1391 1450 1385 1438 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Temperature day 7, &#176;C</td><td char="(" align="char">37.5 (35.6&#8211;39.8)</td><td char="(" align="char">38.2 (34.0&#8211;40.0)</td><td align="left"/></tr>
###xml 1450 1478 1438 1460 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Temperature day 14, &#176;C</td>
###xml 1478 1494 1460 1476 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">38.1 (35.5&#8211;39.3)</td>
###xml 1494 1510 1476 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">38.1 (37.2&#8211;39.9)</td>
###xml 1510 1510 1492 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1450 1510 1438 1492 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Temperature day 14, &#176;C</td><td char="(" align="char">38.1 (35.5&#8211;39.3)</td><td char="(" align="char">38.1 (37.2&#8211;39.9)</td><td align="left"/></tr>
###xml 1510 1534 1492 1516 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Number of failing organs</td>
###xml 1534 1541 1516 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (1&#8211;6)</td>
###xml 1541 1548 1523 1530 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (1&#8211;7)</td>
###xml 1548 1553 1530 1535 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.425</td>
###xml 1510 1553 1492 1535 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Number of failing organs</td><td char="(" align="char">2 (1&#8211;6)</td><td char="(" align="char">2 (1&#8211;7)</td><td char="." align="char">0.425</td></tr>
###xml 1553 1576 1535 1558 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Severity of lung injury</td>
###xml 1576 1576 1558 1558 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1576 1576 1558 1558 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1576 1581 1558 1563 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.869</td>
###xml 1553 1581 1535 1563 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Severity of lung injury</td><td align="left"/><td align="left"/><td char="." align="char">0.869</td></tr>
###xml 1581 1589 1563 1571 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;Non-ALI</td>
###xml 1589 1594 1571 1576 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (9)</td>
###xml 1594 1599 1576 1581 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (7)</td>
###xml 1599 1599 1581 1581 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1581 1599 1563 1581 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;Non-ALI</td><td char="(" align="char">3 (9)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr>
###xml 1599 1603 1581 1585 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;ALI</td>
###xml 1603 1609 1585 1591 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9 (26)</td>
###xml 1609 1614 1591 1596 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (9)</td>
###xml 1614 1614 1596 1596 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1599 1614 1581 1596 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;ALI</td><td char="(" align="char">9 (26)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr>
###xml 1614 1619 1596 1601 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;ARDS</td>
###xml 1619 1626 1601 1608 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">23 (66)</td>
###xml 1626 1633 1608 1615 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (73)</td>
###xml 1633 1633 1615 1615 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1614 1633 1596 1615 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;ARDS</td><td char="(" align="char">23 (66)</td><td char="(" align="char">11 (73)</td><td align="left"/></tr>
###xml 1633 1652 1615 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ICU-acquired sepsis</td>
###xml 1652 1658 1634 1640 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (12)</td>
###xml 1658 1663 1640 1645 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (6)</td>
###xml 1663 1668 1645 1650 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1.000</td>
###xml 1633 1668 1615 1650 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">ICU-acquired sepsis</td><td char="(" align="char">4 (12)</td><td char="(" align="char">1 (6)</td><td char="." align="char">1.000</td></tr>
###xml 1668 1683 1650 1665 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APACHE II score</td>
###xml 1683 1698 1665 1680 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">20.5 (9.0&#8211;34.0)</td>
###xml 1698 1714 1680 1696 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">22.0 (18.0&#8211;53.0)</td>
###xml 1714 1719 1696 1701 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.014</td>
###xml 1668 1719 1650 1701 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APACHE II score</td><td char="(" align="char">20.5 (9.0&#8211;34.0)</td><td char="(" align="char">22.0 (18.0&#8211;53.0)</td><td char="." align="char">0.014</td></tr>
###xml 1719 1739 1701 1721 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Ventilator-free days</td>
###xml 1739 1748 1721 1730 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14 (0&#8211;27)</td>
###xml 1748 1749 1730 1731 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0</td>
###xml 1749 1755 1731 1737 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 1719 1755 1701 1737 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Ventilator-free days</td><td char="(" align="char">14 (0&#8211;27)</td><td char="(" align="char">0</td><td char="." align="char">&lt;0.001</td></tr>
###xml 1755 1769 1737 1751 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">ICU stay, days</td>
###xml 1769 1778 1751 1760 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (2&#8211;86)</td>
###xml 1778 1786 1760 1768 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (1&#8211;68)</td>
###xml 1786 1791 1768 1773 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.056</td>
###xml 1755 1791 1737 1773 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">ICU stay, days</td><td char="(" align="char">13 (2&#8211;86)</td><td char="(" align="char">6 (1&#8211;68)</td><td char="." align="char">0.056</td></tr>
###xml 1791 1810 1773 1792 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hospital stay, days</td>
###xml 1810 1820 1792 1802 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">53 (6&#8211;146)</td>
###xml 1820 1829 1802 1811 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (1&#8211;83)</td>
###xml 1829 1834 1811 1816 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.002</td>
###xml 1791 1834 1773 1816 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hospital stay, days</td><td char="(" align="char">53 (6&#8211;146)</td><td char="(" align="char">10 (1&#8211;83)</td><td char="." align="char">0.002</td></tr>
###xml 802 1834 802 1816 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Age, year</td><td char="(" align="char">68 (21&#8211;87)</td><td char="(" align="char">65 (30&#8211;102)</td><td char="." align="char">0.427</td></tr><tr><td align="left">Sex, male</td><td char="(" align="char">21 (60)</td><td char="(" align="char">13 (87)</td><td char="." align="char">0.099</td></tr><tr><td align="left">Surgery prior to sepsis</td><td char="(" align="char">17 (49)</td><td char="(" align="char">9 (60)</td><td char="." align="char">0.459</td></tr><tr><td align="left">Source of sepsis</td><td align="left"/><td align="left"/><td char="." align="char">0.529</td></tr><tr><td align="left">&#160;Pulmonary</td><td char="(" align="char">15 (43)</td><td char="(" align="char">9 (60)</td><td align="left"/></tr><tr><td align="left">&#160;Abdominal</td><td char="(" align="char">15 (43)</td><td char="(" align="char">5 (33)</td><td align="left"/></tr><tr><td align="left">&#160;Urogenital</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr><tr><td align="left">&#160;Pressure sores</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="(" align="char">5 (14)</td><td char="(" align="char">2 (13)</td><td align="left"/></tr><tr><td align="left">Culture results</td><td align="left"/><td align="left"/><td char="." align="char">0.241</td></tr><tr><td align="left">&#160;Blood gram &#8722;</td><td char="(" align="char">2 (6)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">&#160;Blood gram +</td><td char="(" align="char">0</td><td char="(" align="char">2 (13)</td><td align="left"/></tr><tr><td align="left">&#160;Local<sup>a</sup> gram &#8722;</td><td char="(" align="char">5 (14)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr><tr><td align="left">&#160;Local<sup>a</sup> gram +</td><td char="(" align="char">7 (20)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">Leukocytes day 0,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">11.9 (2.8&#8211;86.0)</td><td char="(" align="char">2.7 (0.4&#8211;74.8)</td><td char="." align="char">0.661, 0.209</td></tr><tr><td align="left">Leukocytes day 7,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">15.6 (5.6&#8211;54.5)</td><td char="(" align="char">11.3 (1.7&#8211;243.1)</td><td align="left"/></tr><tr><td align="left">Leukocytes day 14,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">12.8 (7.5&#8211;33.8)</td><td char="(" align="char">18.8 (4.1&#8211;101.0)</td><td align="left"/></tr><tr><td align="left">Temperature day 0, &#176;C</td><td char="(" align="char">37.7 (34.4&#8211;41.2)</td><td char="(" align="char">38.0 (34.3&#8211;40.4)</td><td char="." align="char">0.288, 0.600</td></tr><tr><td align="left">Temperature day 7, &#176;C</td><td char="(" align="char">37.5 (35.6&#8211;39.8)</td><td char="(" align="char">38.2 (34.0&#8211;40.0)</td><td align="left"/></tr><tr><td align="left">Temperature day 14, &#176;C</td><td char="(" align="char">38.1 (35.5&#8211;39.3)</td><td char="(" align="char">38.1 (37.2&#8211;39.9)</td><td align="left"/></tr><tr><td align="left">Number of failing organs</td><td char="(" align="char">2 (1&#8211;6)</td><td char="(" align="char">2 (1&#8211;7)</td><td char="." align="char">0.425</td></tr><tr><td align="left">Severity of lung injury</td><td align="left"/><td align="left"/><td char="." align="char">0.869</td></tr><tr><td align="left">&#160;Non-ALI</td><td char="(" align="char">3 (9)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">&#160;ALI</td><td char="(" align="char">9 (26)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr><tr><td align="left">&#160;ARDS</td><td char="(" align="char">23 (66)</td><td char="(" align="char">11 (73)</td><td align="left"/></tr><tr><td align="left">ICU-acquired sepsis</td><td char="(" align="char">4 (12)</td><td char="(" align="char">1 (6)</td><td char="." align="char">1.000</td></tr><tr><td align="left">APACHE II score</td><td char="(" align="char">20.5 (9.0&#8211;34.0)</td><td char="(" align="char">22.0 (18.0&#8211;53.0)</td><td char="." align="char">0.014</td></tr><tr><td align="left">Ventilator-free days</td><td char="(" align="char">14 (0&#8211;27)</td><td char="(" align="char">0</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">ICU stay, days</td><td char="(" align="char">13 (2&#8211;86)</td><td char="(" align="char">6 (1&#8211;68)</td><td char="." align="char">0.056</td></tr><tr><td align="left">Hospital stay, days</td><td char="(" align="char">53 (6&#8211;146)</td><td char="(" align="char">10 (1&#8211;83)</td><td char="." align="char">0.002</td></tr></tbody>
###xml 757 1834 757 1816 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Survivors<break/>(<italic>n</italic>&#160;=&#160;35)</th><th align="left">Non-survivors<break/>(<italic>n</italic>&#160;=&#160;15)</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left">Age, year</td><td char="(" align="char">68 (21&#8211;87)</td><td char="(" align="char">65 (30&#8211;102)</td><td char="." align="char">0.427</td></tr><tr><td align="left">Sex, male</td><td char="(" align="char">21 (60)</td><td char="(" align="char">13 (87)</td><td char="." align="char">0.099</td></tr><tr><td align="left">Surgery prior to sepsis</td><td char="(" align="char">17 (49)</td><td char="(" align="char">9 (60)</td><td char="." align="char">0.459</td></tr><tr><td align="left">Source of sepsis</td><td align="left"/><td align="left"/><td char="." align="char">0.529</td></tr><tr><td align="left">&#160;Pulmonary</td><td char="(" align="char">15 (43)</td><td char="(" align="char">9 (60)</td><td align="left"/></tr><tr><td align="left">&#160;Abdominal</td><td char="(" align="char">15 (43)</td><td char="(" align="char">5 (33)</td><td align="left"/></tr><tr><td align="left">&#160;Urogenital</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr><tr><td align="left">&#160;Pressure sores</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="(" align="char">5 (14)</td><td char="(" align="char">2 (13)</td><td align="left"/></tr><tr><td align="left">Culture results</td><td align="left"/><td align="left"/><td char="." align="char">0.241</td></tr><tr><td align="left">&#160;Blood gram &#8722;</td><td char="(" align="char">2 (6)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">&#160;Blood gram +</td><td char="(" align="char">0</td><td char="(" align="char">2 (13)</td><td align="left"/></tr><tr><td align="left">&#160;Local<sup>a</sup> gram &#8722;</td><td char="(" align="char">5 (14)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr><tr><td align="left">&#160;Local<sup>a</sup> gram +</td><td char="(" align="char">7 (20)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">Leukocytes day 0,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">11.9 (2.8&#8211;86.0)</td><td char="(" align="char">2.7 (0.4&#8211;74.8)</td><td char="." align="char">0.661, 0.209</td></tr><tr><td align="left">Leukocytes day 7,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">15.6 (5.6&#8211;54.5)</td><td char="(" align="char">11.3 (1.7&#8211;243.1)</td><td align="left"/></tr><tr><td align="left">Leukocytes day 14,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">12.8 (7.5&#8211;33.8)</td><td char="(" align="char">18.8 (4.1&#8211;101.0)</td><td align="left"/></tr><tr><td align="left">Temperature day 0, &#176;C</td><td char="(" align="char">37.7 (34.4&#8211;41.2)</td><td char="(" align="char">38.0 (34.3&#8211;40.4)</td><td char="." align="char">0.288, 0.600</td></tr><tr><td align="left">Temperature day 7, &#176;C</td><td char="(" align="char">37.5 (35.6&#8211;39.8)</td><td char="(" align="char">38.2 (34.0&#8211;40.0)</td><td align="left"/></tr><tr><td align="left">Temperature day 14, &#176;C</td><td char="(" align="char">38.1 (35.5&#8211;39.3)</td><td char="(" align="char">38.1 (37.2&#8211;39.9)</td><td align="left"/></tr><tr><td align="left">Number of failing organs</td><td char="(" align="char">2 (1&#8211;6)</td><td char="(" align="char">2 (1&#8211;7)</td><td char="." align="char">0.425</td></tr><tr><td align="left">Severity of lung injury</td><td align="left"/><td align="left"/><td char="." align="char">0.869</td></tr><tr><td align="left">&#160;Non-ALI</td><td char="(" align="char">3 (9)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">&#160;ALI</td><td char="(" align="char">9 (26)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr><tr><td align="left">&#160;ARDS</td><td char="(" align="char">23 (66)</td><td char="(" align="char">11 (73)</td><td align="left"/></tr><tr><td align="left">ICU-acquired sepsis</td><td char="(" align="char">4 (12)</td><td char="(" align="char">1 (6)</td><td char="." align="char">1.000</td></tr><tr><td align="left">APACHE II score</td><td char="(" align="char">20.5 (9.0&#8211;34.0)</td><td char="(" align="char">22.0 (18.0&#8211;53.0)</td><td char="." align="char">0.014</td></tr><tr><td align="left">Ventilator-free days</td><td char="(" align="char">14 (0&#8211;27)</td><td char="(" align="char">0</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">ICU stay, days</td><td char="(" align="char">13 (2&#8211;86)</td><td char="(" align="char">6 (1&#8211;68)</td><td char="." align="char">0.056</td></tr><tr><td align="left">Hospital stay, days</td><td char="(" align="char">53 (6&#8211;146)</td><td char="(" align="char">10 (1&#8211;83)</td><td char="." align="char">0.002</td></tr></tbody></table>
###xml 1919 1920 1901 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1834 2012 1816 1994 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23">Variables are expressed as median (range) or as number of patients (percentage) with <italic>P</italic> value (survivor vs. non-survivor and interaction between day and survivor vs. non-survivor)</p>
###xml 2012 2019 1994 2001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Non-ALI</italic>
###xml 2074 2075 2056 2057 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2107 2108 2089 2090 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2119 2120 2101 2102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2120 2121 2102 2103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 2122 2123 2104 2105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2124 2125 2106 2107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 2125 2126 2107 2108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 2127 2128 2109 2110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2150 2153 2132 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ALI</italic>
###xml 2165 2166 2147 2148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2166 2167 2148 2149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 2168 2169 2150 2151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2170 2171 2152 2153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 2171 2172 2153 2154 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 2173 2174 2155 2156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2206 2210 2186 2190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARDS</italic>
###xml 2258 2259 2238 2239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2259 2260 2239 2240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 2261 2262 2241 2242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2263 2264 2243 2244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 2264 2265 2244 2245 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 2266 2267 2246 2247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2290 2293 2268 2271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ICU</italic>
###xml 2315 2321 2293 2299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APACHE</italic>
###xml 2012 2368 1994 2346 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24"><italic>Non-ALI</italic> non-acute lung injury defined as partial pressure of O<sub>2</sub> in arterial blood/inspiratory O<sub>2</sub> fraction (<italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub>) at day 0 &gt;300&#160;mmHg, <italic>ALI</italic> defined as <italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub> at day 0 &gt;200 and &#8804;300&#160;mmHg, <italic>ARDS</italic> acute respiratory distress syndrome defined as <italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub> at day 0 &#8804;200&#160;mmHg, <italic>ICU</italic> intensive care unit, <italic>APACHE</italic> Acute Physiology And Chronic Health Evaluation</p>
###xml 2368 2369 2346 2347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2368 2402 2346 2380 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><sup>a</sup>Local when blood-culture negative</p>
###xml 1834 2402 1816 2380 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23">Variables are expressed as median (range) or as number of patients (percentage) with <italic>P</italic> value (survivor vs. non-survivor and interaction between day and survivor vs. non-survivor)</p><p textid="24"><italic>Non-ALI</italic> non-acute lung injury defined as partial pressure of O<sub>2</sub> in arterial blood/inspiratory O<sub>2</sub> fraction (<italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub>) at day 0 &gt;300&#160;mmHg, <italic>ALI</italic> defined as <italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub> at day 0 &gt;200 and &#8804;300&#160;mmHg, <italic>ARDS</italic> acute respiratory distress syndrome defined as <italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub> at day 0 &#8804;200&#160;mmHg, <italic>ICU</italic> intensive care unit, <italic>APACHE</italic> Acute Physiology And Chronic Health Evaluation</p><p textid="25"><sup>a</sup>Local when blood-culture negative</p></table-wrap-foot>
###xml 679 2402 679 2380 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="22">Demographic and clinical characteristics of survivors and non-survivors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Survivors<break/>(<italic>n</italic>&#160;=&#160;35)</th><th align="left">Non-survivors<break/>(<italic>n</italic>&#160;=&#160;15)</th><th align="left"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left">Age, year</td><td char="(" align="char">68 (21&#8211;87)</td><td char="(" align="char">65 (30&#8211;102)</td><td char="." align="char">0.427</td></tr><tr><td align="left">Sex, male</td><td char="(" align="char">21 (60)</td><td char="(" align="char">13 (87)</td><td char="." align="char">0.099</td></tr><tr><td align="left">Surgery prior to sepsis</td><td char="(" align="char">17 (49)</td><td char="(" align="char">9 (60)</td><td char="." align="char">0.459</td></tr><tr><td align="left">Source of sepsis</td><td align="left"/><td align="left"/><td char="." align="char">0.529</td></tr><tr><td align="left">&#160;Pulmonary</td><td char="(" align="char">15 (43)</td><td char="(" align="char">9 (60)</td><td align="left"/></tr><tr><td align="left">&#160;Abdominal</td><td char="(" align="char">15 (43)</td><td char="(" align="char">5 (33)</td><td align="left"/></tr><tr><td align="left">&#160;Urogenital</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr><tr><td align="left">&#160;Pressure sores</td><td char="(" align="char">1 (3)</td><td char="(" align="char">0</td><td align="left"/></tr><tr><td align="left">&#160;Unknown</td><td char="(" align="char">5 (14)</td><td char="(" align="char">2 (13)</td><td align="left"/></tr><tr><td align="left">Culture results</td><td align="left"/><td align="left"/><td char="." align="char">0.241</td></tr><tr><td align="left">&#160;Blood gram &#8722;</td><td char="(" align="char">2 (6)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">&#160;Blood gram +</td><td char="(" align="char">0</td><td char="(" align="char">2 (13)</td><td align="left"/></tr><tr><td align="left">&#160;Local<sup>a</sup> gram &#8722;</td><td char="(" align="char">5 (14)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr><tr><td align="left">&#160;Local<sup>a</sup> gram +</td><td char="(" align="char">7 (20)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">Leukocytes day 0,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">11.9 (2.8&#8211;86.0)</td><td char="(" align="char">2.7 (0.4&#8211;74.8)</td><td char="." align="char">0.661, 0.209</td></tr><tr><td align="left">Leukocytes day 7,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">15.6 (5.6&#8211;54.5)</td><td char="(" align="char">11.3 (1.7&#8211;243.1)</td><td align="left"/></tr><tr><td align="left">Leukocytes day 14,&#160;&#215;10<sup>9</sup>/l</td><td char="(" align="char">12.8 (7.5&#8211;33.8)</td><td char="(" align="char">18.8 (4.1&#8211;101.0)</td><td align="left"/></tr><tr><td align="left">Temperature day 0, &#176;C</td><td char="(" align="char">37.7 (34.4&#8211;41.2)</td><td char="(" align="char">38.0 (34.3&#8211;40.4)</td><td char="." align="char">0.288, 0.600</td></tr><tr><td align="left">Temperature day 7, &#176;C</td><td char="(" align="char">37.5 (35.6&#8211;39.8)</td><td char="(" align="char">38.2 (34.0&#8211;40.0)</td><td align="left"/></tr><tr><td align="left">Temperature day 14, &#176;C</td><td char="(" align="char">38.1 (35.5&#8211;39.3)</td><td char="(" align="char">38.1 (37.2&#8211;39.9)</td><td align="left"/></tr><tr><td align="left">Number of failing organs</td><td char="(" align="char">2 (1&#8211;6)</td><td char="(" align="char">2 (1&#8211;7)</td><td char="." align="char">0.425</td></tr><tr><td align="left">Severity of lung injury</td><td align="left"/><td align="left"/><td char="." align="char">0.869</td></tr><tr><td align="left">&#160;Non-ALI</td><td char="(" align="char">3 (9)</td><td char="(" align="char">1 (7)</td><td align="left"/></tr><tr><td align="left">&#160;ALI</td><td char="(" align="char">9 (26)</td><td char="(" align="char">3 (9)</td><td align="left"/></tr><tr><td align="left">&#160;ARDS</td><td char="(" align="char">23 (66)</td><td char="(" align="char">11 (73)</td><td align="left"/></tr><tr><td align="left">ICU-acquired sepsis</td><td char="(" align="char">4 (12)</td><td char="(" align="char">1 (6)</td><td char="." align="char">1.000</td></tr><tr><td align="left">APACHE II score</td><td char="(" align="char">20.5 (9.0&#8211;34.0)</td><td char="(" align="char">22.0 (18.0&#8211;53.0)</td><td char="." align="char">0.014</td></tr><tr><td align="left">Ventilator-free days</td><td char="(" align="char">14 (0&#8211;27)</td><td char="(" align="char">0</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">ICU stay, days</td><td char="(" align="char">13 (2&#8211;86)</td><td char="(" align="char">6 (1&#8211;68)</td><td char="." align="char">0.056</td></tr><tr><td align="left">Hospital stay, days</td><td char="(" align="char">53 (6&#8211;146)</td><td char="(" align="char">10 (1&#8211;83)</td><td char="." align="char">0.002</td></tr></tbody></table><table-wrap-foot><p textid="23">Variables are expressed as median (range) or as number of patients (percentage) with <italic>P</italic> value (survivor vs. non-survivor and interaction between day and survivor vs. non-survivor)</p><p textid="24"><italic>Non-ALI</italic> non-acute lung injury defined as partial pressure of O<sub>2</sub> in arterial blood/inspiratory O<sub>2</sub> fraction (<italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub>) at day 0 &gt;300&#160;mmHg, <italic>ALI</italic> defined as <italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub> at day 0 &gt;200 and &#8804;300&#160;mmHg, <italic>ARDS</italic> acute respiratory distress syndrome defined as <italic>P</italic><sub>a</sub>O<sub>2</sub>/<italic>F</italic><sub>i</sub>O<sub>2</sub> at day 0 &#8804;200&#160;mmHg, <italic>ICU</italic> intensive care unit, <italic>APACHE</italic> Acute Physiology And Chronic Health Evaluation</p><p textid="25"><sup>a</sup>Local when blood-culture negative</p></table-wrap-foot></table-wrap>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 1892 1900 <span type="species:ncbi:9606">patients</span>
Patients were grouped as ICU survivor or non-survivor (Table 1, ESM Table 1). All ICU non-survivors, except one (death on day 68), died before ICU day 28. Five ICU survivors died in the hospital at a median 24 (range 2-60) days after discharge from the ICU. ICU survivors and non-survivors were comparable with respect to baseline demographics and with respect to clinical characteristics, except for APACHE II score and hospital stay, which were higher and shorter, respectively, in non-survivors compared to survivors. Twenty-two survivors and 14 non-survivors suffered from ALI/ARDS (Table 1). Haemodynamic, biochemical and respiratory characteristics are reported in the ESM.Table 1Demographic and clinical characteristics of survivors and non-survivorsSurvivors(n = 35)Non-survivors(n = 15)P valueAge, year68 (21-87)65 (30-102)0.427Sex, male21 (60)13 (87)0.099Surgery prior to sepsis17 (49)9 (60)0.459Source of sepsis0.529 Pulmonary15 (43)9 (60) Abdominal15 (43)5 (33) Urogenital1 (3)0 Pressure sores1 (3)0 Unknown5 (14)2 (13)Culture results0.241 Blood gram -2 (6)1 (7) Blood gram +02 (13) Locala gram -5 (14)3 (9) Locala gram +7 (20)1 (7)Leukocytes day 0, x109/l11.9 (2.8-86.0)2.7 (0.4-74.8)0.661, 0.209Leukocytes day 7, x109/l15.6 (5.6-54.5)11.3 (1.7-243.1)Leukocytes day 14, x109/l12.8 (7.5-33.8)18.8 (4.1-101.0)Temperature day 0, degreesC37.7 (34.4-41.2)38.0 (34.3-40.4)0.288, 0.600Temperature day 7, degreesC37.5 (35.6-39.8)38.2 (34.0-40.0)Temperature day 14, degreesC38.1 (35.5-39.3)38.1 (37.2-39.9)Number of failing organs2 (1-6)2 (1-7)0.425Severity of lung injury0.869 Non-ALI3 (9)1 (7) ALI9 (26)3 (9) ARDS23 (66)11 (73)ICU-acquired sepsis4 (12)1 (6)1.000APACHE II score20.5 (9.0-34.0)22.0 (18.0-53.0)0.014Ventilator-free days14 (0-27)0<0.001ICU stay, days13 (2-86)6 (1-68)0.056Hospital stay, days53 (6-146)10 (1-83)0.002Variables are expressed as median (range) or as number of patients (percentage) with P value (survivor vs. non-survivor and interaction between day and survivor vs. non-survivor)Non-ALI non-acute lung injury defined as partial pressure of O2 in arterial blood/inspiratory O2 fraction (PaO2/FiO2) at day 0 >300 mmHg, ALI defined as PaO2/FiO2 at day 0 >200 and </=300 mmHg, ARDS acute respiratory distress syndrome defined as PaO2/FiO2 at day 0 </=200 mmHg, ICU intensive care unit, APACHE Acute Physiology And Chronic Health EvaluationaLocal when blood-culture negative
###end p 21
###begin p 22
Demographic and clinical characteristics of survivors and non-survivors
###end p 22
###begin p 23
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Variables are expressed as median (range) or as number of patients (percentage) with P value (survivor vs. non-survivor and interaction between day and survivor vs. non-survivor)
###end p 23
###begin p 24
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Non-ALI</italic>
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 110 111 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 112 113 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 113 114 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ALI</italic>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 156 157 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 161 162 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 194 198 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARDS</italic>
###xml 246 247 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 247 248 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 249 250 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 251 252 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 252 253 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 254 255 252 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 278 281 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ICU</italic>
###xml 303 309 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APACHE</italic>
Non-ALI non-acute lung injury defined as partial pressure of O2 in arterial blood/inspiratory O2 fraction (PaO2/FiO2) at day 0 >300 mmHg, ALI defined as PaO2/FiO2 at day 0 >200 and </=300 mmHg, ARDS acute respiratory distress syndrome defined as PaO2/FiO2 at day 0 </=200 mmHg, ICU intensive care unit, APACHE Acute Physiology And Chronic Health Evaluation
###end p 24
###begin p 25
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aLocal when blood-culture negative
###end p 25
###begin title 26
Angiopoietin and VWF levels, fluid balance and pulmonary dysfunction
###end title 26
###begin p 27
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 360 361 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 536 540 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 549 550 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 567 568 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 577 578 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 749 750 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 750 751 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 752 753 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 754 755 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 755 756 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 757 758 754 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 766 770 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 780 781 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 798 799 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 809 810 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 869 873 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 882 883 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 900 901 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 910 911 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 967 971 958 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 981 982 969 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 999 1000 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1010 1011 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1073 1074 1061 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1149 1153 1137 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1163 1164 1148 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1181 1182 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1192 1193 1177 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1242 1246 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1255 1256 1237 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1273 1274 1255 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1283 1284 1265 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1574 1576 1556 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> P</italic>
###xml 1576 1577 1558 1559 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 1578 1579 1560 1561 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1580 1581 1562 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1581 1582 1563 1564 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1583 1584 1565 1566 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1592 1596 1574 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1606 1607 1585 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1624 1625 1603 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1635 1636 1614 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1698 1702 1677 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1711 1712 1687 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1729 1730 1705 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 1739 1740 1715 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1940 1942 1916 1918 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> P</italic>
###xml 1942 1943 1918 1919 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 1944 1945 1920 1921 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1946 1947 1922 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1947 1948 1923 1924 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1949 1950 1925 1926 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1958 1962 1934 1935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1972 1973 1945 1946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1990 1991 1963 1964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 2001 2002 1974 1975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2061 2065 2034 2035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 2074 2075 2044 2045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2092 2093 2062 2063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 2102 2103 2072 2073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2158 2162 2128 2129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 2172 2173 2139 2140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2190 2191 2157 2158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 2201 2202 2168 2169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 255 263 <span type="species:ncbi:9606">Patients</span>
Patients had higher Ang-2 and VWF levels on day 0 [median (interquartile range) 2,350 (1,400-4,280) pg/ml and 289 (166-411)% of reference, respectively] than controls [113 (27-287) pg/ml, P < 0.001 and 93 (87-113)% of reference, P < 0.001, respectively]. Patients had lower Ang-1 levels on day 0 [330 (114-1,020) pg/ml] than controls [2,407 (969-3,730) pg/ml, P < 0.001]. Ang-2 levels related positively to the fluid balance throughout the course of septic shock after exclusion of one non-survivor who had extremely high Ang-2 levels (beta = 0.20, P = 0.043 in GEE, r = 0.30, P = 0.005). Furthermore, Ang-2 levels related to indicators of pulmonary dysfunction throughout the course of septic shock, as demonstrated by an inverse relation with the PaO2/FiO2 ratio (beta = -0.25, P < 0.001 in GEE; r = -0.25, P = 0.012), a positive relation with the oxygenation index (beta = 0.37, P < 0.001 in GEE; r = 0.26, P = 0.017), a weak inverse relation with the compliance (beta = -0.09, P = 0.004 in GEE; r = -0.05, P = 0.645) and a positive relation with ventilator-dependency (P = 0.043 in GEE). In contrast, VWF inversely related to the fluid balance (beta = -0.21, P = 0.045 in GEE; r = -0.27, P = 0.014), positively related to the compliance (beta = 0.21, P = 0.011 in GEE; r = 0.17, P = 0.134) and did not relate to the other respiratory variables throughout the course of septic shock. Ang-1 levels did not relate to the fluid balance, but related to indicators of pulmonary dysfunction throughout the course of septic shock, as demonstrated by an inverse relation with the PaO2/FiO2 ratio (beta = -0.26, P = 0.022 in GEE; r = -0.21, P = 0.034) and a positive relation with the oxygenation index (beta = 0.37, P = 0.005 in GEE; r = 0.28, P = 0.014) throughout the course of septic shock. The fluid balance related to indicators of pulmonary dysfunction throughout the course of septic shock, as demonstrated by an inverse relation with the PaO2/FiO2 ratio (beta = -0.24, P < 0.001 in GEE; r = -0.29, P = 0.006), a positive relation with the oxygenation index (beta = 0.22, P = 0.006 in GEE; r = 0.22, P = 0.068) and an inverse relation with the compliance (beta = -0.26, P = 0.006 in GEE; r = -0.29, P = 0.014).
###end p 27
###begin title 28
The course of the angiopoietin and VWF levels in survivors and non-survivors
###end title 28
###begin p 29
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 628 629 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 785 791 785 791 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 899 900 899 900 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 944 945 944 945 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 994 995 994 995 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1084 1095 1084 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circle</italic>
###xml 1120 1133 1120 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled circle</italic>
###xml 1251 1252 1251 1252 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1360 1361 1360 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1404 1405 1404 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1752 1753 1752 1753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1799 1800 1799 1800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1875 1876 1875 1876 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1978 1979 1978 1979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2022 2023 2022 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2092 2093 2092 2093 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2197 2198 2197 2198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2241 2242 2241 2242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 791 2309 791 2309 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">The course of angiopoietin and VWF levels in survivors and non-survivors. Median and interquartile range of <bold>a</bold> circulating angiopoietin-2 (Ang-2; pg/ml), <bold>b</bold> von Willebrand factor (VWF; % of reference) and <bold>c</bold> angiopoietin-1 (Ang-1) levels (pg/ml) in plasma of intensive care unit (ICU) survivors (<italic>open circle</italic>) and ICU non-survivors (<italic>filled circle</italic>) on day 0, 1, 2, 4 and 7. Days 14, 21 and 28 are not shown because of low numbers, but are included in the analysis. <bold>a</bold> Ang-2 levels tended to be higher in non-survivors than in survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.199 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.028 for interaction between day and survivor vs. non-survivor). One non-survivor had extremely high Ang-2 levels: day 0 125,100&#160;pg/ml; day 1 149,000&#160;pg/ml; day 2 114,300&#160;pg/ml; day 4 115,550&#160;pg/ml and day 7 116,800&#160;pg/ml. Therefore, the upper limit of interquartile range at day 7 is 88,263&#160;pg/ml. Analysis without this non-survivor yields a <italic>P</italic>&#160;=&#160;0.039 for survivor versus non-survivor and <italic>P</italic>&#160;=&#160;0.016 for the interaction between day and survivor versus non-survivor. <bold>b</bold> VWF levels did not differ between survivors and non-survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.545 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.218 for interaction between day and survivor vs. non-survivor). <bold>c</bold> Ang-1 levels did not differ between survivors and non-survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.189 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.070 for interaction between day and survivor vs. non-survivor)</p>
###xml 791 2309 791 2309 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30">The course of angiopoietin and VWF levels in survivors and non-survivors. Median and interquartile range of <bold>a</bold> circulating angiopoietin-2 (Ang-2; pg/ml), <bold>b</bold> von Willebrand factor (VWF; % of reference) and <bold>c</bold> angiopoietin-1 (Ang-1) levels (pg/ml) in plasma of intensive care unit (ICU) survivors (<italic>open circle</italic>) and ICU non-survivors (<italic>filled circle</italic>) on day 0, 1, 2, 4 and 7. Days 14, 21 and 28 are not shown because of low numbers, but are included in the analysis. <bold>a</bold> Ang-2 levels tended to be higher in non-survivors than in survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.199 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.028 for interaction between day and survivor vs. non-survivor). One non-survivor had extremely high Ang-2 levels: day 0 125,100&#160;pg/ml; day 1 149,000&#160;pg/ml; day 2 114,300&#160;pg/ml; day 4 115,550&#160;pg/ml and day 7 116,800&#160;pg/ml. Therefore, the upper limit of interquartile range at day 7 is 88,263&#160;pg/ml. Analysis without this non-survivor yields a <italic>P</italic>&#160;=&#160;0.039 for survivor versus non-survivor and <italic>P</italic>&#160;=&#160;0.016 for the interaction between day and survivor versus non-survivor. <bold>b</bold> VWF levels did not differ between survivors and non-survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.545 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.218 for interaction between day and survivor vs. non-survivor). <bold>c</bold> Ang-1 levels did not differ between survivors and non-survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.189 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.070 for interaction between day and survivor vs. non-survivor)</p></caption>
###xml 2309 2309 2309 2309 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="134_2009_1560_Fig1_HTML" id="MO1"/>
###xml 785 2309 785 2309 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="30">The course of angiopoietin and VWF levels in survivors and non-survivors. Median and interquartile range of <bold>a</bold> circulating angiopoietin-2 (Ang-2; pg/ml), <bold>b</bold> von Willebrand factor (VWF; % of reference) and <bold>c</bold> angiopoietin-1 (Ang-1) levels (pg/ml) in plasma of intensive care unit (ICU) survivors (<italic>open circle</italic>) and ICU non-survivors (<italic>filled circle</italic>) on day 0, 1, 2, 4 and 7. Days 14, 21 and 28 are not shown because of low numbers, but are included in the analysis. <bold>a</bold> Ang-2 levels tended to be higher in non-survivors than in survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.199 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.028 for interaction between day and survivor vs. non-survivor). One non-survivor had extremely high Ang-2 levels: day 0 125,100&#160;pg/ml; day 1 149,000&#160;pg/ml; day 2 114,300&#160;pg/ml; day 4 115,550&#160;pg/ml and day 7 116,800&#160;pg/ml. Therefore, the upper limit of interquartile range at day 7 is 88,263&#160;pg/ml. Analysis without this non-survivor yields a <italic>P</italic>&#160;=&#160;0.039 for survivor versus non-survivor and <italic>P</italic>&#160;=&#160;0.016 for the interaction between day and survivor versus non-survivor. <bold>b</bold> VWF levels did not differ between survivors and non-survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.545 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.218 for interaction between day and survivor vs. non-survivor). <bold>c</bold> Ang-1 levels did not differ between survivors and non-survivors throughout the course of septic shock (<italic>P</italic>&#160;=&#160;0.189 for survivor vs. non-survivor and <italic>P</italic>&#160;=&#160;0.070 for interaction between day and survivor vs. non-survivor)</p></caption><graphic position="anchor" xlink:href="134_2009_1560_Fig1_HTML" id="MO1"/></fig>
###xml 2309 2315 2309 2315 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 2439 2440 2439 2440 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2484 2485 2484 2485 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2534 2535 2534 2535 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2773 2774 2773 2774 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2844 2845 2844 2845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2856 2857 2856 2857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2915 2916 2915 2916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2927 2928 2927 2928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3202 3203 3202 3203 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3271 3272 3271 3272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3283 3284 3283 3284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3334 3335 3334 3335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3346 3347 3346 3347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3361 3362 3361 3362 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3440 3441 3440 3441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3452 3453 3452 3453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3484 3485 3484 3485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3496 3497 3496 3497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2315 3509 2315 3509 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">Angiopoietin and VWF levels on day 0 and the last ICU day in survivors and non-survivors. Individual levels and box plot of <bold>a</bold> circulating angiopoietin-2 (Ang-2; pg/ml), <bold>b</bold> von Willebrand factor (VWF; % of reference) and <bold>c</bold> angiopoietin-1 (Ang-1) levels (pg/ml) on day 0 and the last intensive care unit (ICU) day in ICU survivors and ICU non-survivors. Values in boxes are at 25th percentile, median and 75th percentile; whiskers are 10th and 90th percentile. <bold>a</bold> Ang-2 levels decreased from day 0 to the last ICU day in survivors (*<italic>P</italic>&#160;=&#160;0.0033, <italic>n</italic>&#160;=&#160;35 pairs), while they did not change in non-survivors (<italic>P</italic>&#160;=&#160;0.3910, <italic>n</italic>&#160;=&#160;15 pairs). Data not shown: Day 0 survivor: 25,090&#160;pg/ml; day 0 non-survivor: 17,980 and 125,100&#160;pg/ml; last ICU day non-survivor: 12,050 and 116,800&#160;pg/ml; 90th percentile of non-survivors day 0: 60,828&#160;pg/ml; 90th percentile of non-survivors last ICU day: 53,950&#160;pg/ml. <bold>b</bold> VWF levels increased from day 0 to the last ICU day in survivors (*<italic>P</italic>&#160;=&#160;0.0057, <italic>n</italic>&#160;=&#160;35 pairs) and did not change in non-survivors (<italic>P</italic>&#160;=&#160;0.5070, <italic>n</italic>&#160;=&#160;14 pairs). <bold>c</bold> Ang-1 levels did not differ between day 0 and the last ICU day in survivors (<italic>P</italic>&#160;=&#160;0.1044, <italic>n</italic>&#160;=&#160;35 pairs) or non-survivors (<italic>P</italic>&#160;=&#160;0.7612, <italic>n</italic>&#160;=&#160;14 pairs)</p>
###xml 2315 3509 2315 3509 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31">Angiopoietin and VWF levels on day 0 and the last ICU day in survivors and non-survivors. Individual levels and box plot of <bold>a</bold> circulating angiopoietin-2 (Ang-2; pg/ml), <bold>b</bold> von Willebrand factor (VWF; % of reference) and <bold>c</bold> angiopoietin-1 (Ang-1) levels (pg/ml) on day 0 and the last intensive care unit (ICU) day in ICU survivors and ICU non-survivors. Values in boxes are at 25th percentile, median and 75th percentile; whiskers are 10th and 90th percentile. <bold>a</bold> Ang-2 levels decreased from day 0 to the last ICU day in survivors (*<italic>P</italic>&#160;=&#160;0.0033, <italic>n</italic>&#160;=&#160;35 pairs), while they did not change in non-survivors (<italic>P</italic>&#160;=&#160;0.3910, <italic>n</italic>&#160;=&#160;15 pairs). Data not shown: Day 0 survivor: 25,090&#160;pg/ml; day 0 non-survivor: 17,980 and 125,100&#160;pg/ml; last ICU day non-survivor: 12,050 and 116,800&#160;pg/ml; 90th percentile of non-survivors day 0: 60,828&#160;pg/ml; 90th percentile of non-survivors last ICU day: 53,950&#160;pg/ml. <bold>b</bold> VWF levels increased from day 0 to the last ICU day in survivors (*<italic>P</italic>&#160;=&#160;0.0057, <italic>n</italic>&#160;=&#160;35 pairs) and did not change in non-survivors (<italic>P</italic>&#160;=&#160;0.5070, <italic>n</italic>&#160;=&#160;14 pairs). <bold>c</bold> Ang-1 levels did not differ between day 0 and the last ICU day in survivors (<italic>P</italic>&#160;=&#160;0.1044, <italic>n</italic>&#160;=&#160;35 pairs) or non-survivors (<italic>P</italic>&#160;=&#160;0.7612, <italic>n</italic>&#160;=&#160;14 pairs)</p></caption>
###xml 3509 3509 3509 3509 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="134_2009_1560_Fig2_HTML" id="MO2"/>
###xml 2309 3509 2309 3509 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="31">Angiopoietin and VWF levels on day 0 and the last ICU day in survivors and non-survivors. Individual levels and box plot of <bold>a</bold> circulating angiopoietin-2 (Ang-2; pg/ml), <bold>b</bold> von Willebrand factor (VWF; % of reference) and <bold>c</bold> angiopoietin-1 (Ang-1) levels (pg/ml) on day 0 and the last intensive care unit (ICU) day in ICU survivors and ICU non-survivors. Values in boxes are at 25th percentile, median and 75th percentile; whiskers are 10th and 90th percentile. <bold>a</bold> Ang-2 levels decreased from day 0 to the last ICU day in survivors (*<italic>P</italic>&#160;=&#160;0.0033, <italic>n</italic>&#160;=&#160;35 pairs), while they did not change in non-survivors (<italic>P</italic>&#160;=&#160;0.3910, <italic>n</italic>&#160;=&#160;15 pairs). Data not shown: Day 0 survivor: 25,090&#160;pg/ml; day 0 non-survivor: 17,980 and 125,100&#160;pg/ml; last ICU day non-survivor: 12,050 and 116,800&#160;pg/ml; 90th percentile of non-survivors day 0: 60,828&#160;pg/ml; 90th percentile of non-survivors last ICU day: 53,950&#160;pg/ml. <bold>b</bold> VWF levels increased from day 0 to the last ICU day in survivors (*<italic>P</italic>&#160;=&#160;0.0057, <italic>n</italic>&#160;=&#160;35 pairs) and did not change in non-survivors (<italic>P</italic>&#160;=&#160;0.5070, <italic>n</italic>&#160;=&#160;14 pairs). <bold>c</bold> Ang-1 levels did not differ between day 0 and the last ICU day in survivors (<italic>P</italic>&#160;=&#160;0.1044, <italic>n</italic>&#160;=&#160;35 pairs) or non-survivors (<italic>P</italic>&#160;=&#160;0.7612, <italic>n</italic>&#160;=&#160;14 pairs)</p></caption><graphic position="anchor" xlink:href="134_2009_1560_Fig2_HTML" id="MO2"/></fig>
###xml 3509 3515 3509 3515 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 3680 3693 3680 3693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled circle</italic>
###xml 3695 3696 3695 3696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 3705 3706 3705 3706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3716 3726 3716 3726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 3810 3821 3810 3821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circle</italic>
###xml 3877 3878 3877 3878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 3887 3888 3887 3888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 3899 3910 3899 3910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dotted line</italic>
###xml 3515 3911 3515 3911 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">The relation between Ang-2 and VWF levels. Angiopoietin-2 (Ang-2) levels (pg/ml) positively related to von Willebrand factor (VWF) levels (% of reference) at day 0 (<italic>filled circle</italic>, <italic>r</italic>&#160;=&#160;0.45, <italic>P</italic>&#160;=&#160;0.001, <italic>black line</italic>). Ang-2 levels throughout the course of septic shock did not relate to VWF levels (<italic>open circle</italic> day 1, day 2, day 4, day 7, day 14, day 21 and day 28, <italic>r</italic>&#160;=&#160;0.10, <italic>P</italic>&#160;=&#160;0.1190, <italic>dotted line</italic>)</p>
###xml 3515 3911 3515 3911 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">The relation between Ang-2 and VWF levels. Angiopoietin-2 (Ang-2) levels (pg/ml) positively related to von Willebrand factor (VWF) levels (% of reference) at day 0 (<italic>filled circle</italic>, <italic>r</italic>&#160;=&#160;0.45, <italic>P</italic>&#160;=&#160;0.001, <italic>black line</italic>). Ang-2 levels throughout the course of septic shock did not relate to VWF levels (<italic>open circle</italic> day 1, day 2, day 4, day 7, day 14, day 21 and day 28, <italic>r</italic>&#160;=&#160;0.10, <italic>P</italic>&#160;=&#160;0.1190, <italic>dotted line</italic>)</p></caption>
###xml 3911 3911 3911 3911 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="134_2009_1560_Fig3_HTML" id="MO3"/>
###xml 3509 3911 3509 3911 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="32">The relation between Ang-2 and VWF levels. Angiopoietin-2 (Ang-2) levels (pg/ml) positively related to von Willebrand factor (VWF) levels (% of reference) at day 0 (<italic>filled circle</italic>, <italic>r</italic>&#160;=&#160;0.45, <italic>P</italic>&#160;=&#160;0.001, <italic>black line</italic>). Ang-2 levels throughout the course of septic shock did not relate to VWF levels (<italic>open circle</italic> day 1, day 2, day 4, day 7, day 14, day 21 and day 28, <italic>r</italic>&#160;=&#160;0.10, <italic>P</italic>&#160;=&#160;0.1190, <italic>dotted line</italic>)</p></caption><graphic position="anchor" xlink:href="134_2009_1560_Fig3_HTML" id="MO3"/></fig>
Ang-2 levels were higher in non-survivors than in survivors throughout the course of septic shock (Fig. 1). Ang-2 levels decreased in survivors from day 0 to the last ICU day, while they did not change in non-survivors (Figs. 1, 2). The course of VWF levels differed between survivors and non-survivors (Fig. 1), since VWF levels increased in survivors from day 0 to the last ICU day, while they did not change in non-survivors (Fig. 2). Ang-2 levels related to VWF levels on day 0, but the relation was lost throughout the course of septic shock (Fig. 3). Ang-1 levels were comparable between survivors and non-survivors (Fig. 1) and did not change from day 0 to the last ICU day (Fig. 2). The predictive value of angiopoietin and VWF levels for ICU mortality is described in the ESM.Fig. 1The course of angiopoietin and VWF levels in survivors and non-survivors. Median and interquartile range of a circulating angiopoietin-2 (Ang-2; pg/ml), b von Willebrand factor (VWF; % of reference) and c angiopoietin-1 (Ang-1) levels (pg/ml) in plasma of intensive care unit (ICU) survivors (open circle) and ICU non-survivors (filled circle) on day 0, 1, 2, 4 and 7. Days 14, 21 and 28 are not shown because of low numbers, but are included in the analysis. a Ang-2 levels tended to be higher in non-survivors than in survivors throughout the course of septic shock (P = 0.199 for survivor vs. non-survivor and P = 0.028 for interaction between day and survivor vs. non-survivor). One non-survivor had extremely high Ang-2 levels: day 0 125,100 pg/ml; day 1 149,000 pg/ml; day 2 114,300 pg/ml; day 4 115,550 pg/ml and day 7 116,800 pg/ml. Therefore, the upper limit of interquartile range at day 7 is 88,263 pg/ml. Analysis without this non-survivor yields a P = 0.039 for survivor versus non-survivor and P = 0.016 for the interaction between day and survivor versus non-survivor. b VWF levels did not differ between survivors and non-survivors throughout the course of septic shock (P = 0.545 for survivor vs. non-survivor and P = 0.218 for interaction between day and survivor vs. non-survivor). c Ang-1 levels did not differ between survivors and non-survivors throughout the course of septic shock (P = 0.189 for survivor vs. non-survivor and P = 0.070 for interaction between day and survivor vs. non-survivor)Fig. 2Angiopoietin and VWF levels on day 0 and the last ICU day in survivors and non-survivors. Individual levels and box plot of a circulating angiopoietin-2 (Ang-2; pg/ml), b von Willebrand factor (VWF; % of reference) and c angiopoietin-1 (Ang-1) levels (pg/ml) on day 0 and the last intensive care unit (ICU) day in ICU survivors and ICU non-survivors. Values in boxes are at 25th percentile, median and 75th percentile; whiskers are 10th and 90th percentile. a Ang-2 levels decreased from day 0 to the last ICU day in survivors (*P = 0.0033, n = 35 pairs), while they did not change in non-survivors (P = 0.3910, n = 15 pairs). Data not shown: Day 0 survivor: 25,090 pg/ml; day 0 non-survivor: 17,980 and 125,100 pg/ml; last ICU day non-survivor: 12,050 and 116,800 pg/ml; 90th percentile of non-survivors day 0: 60,828 pg/ml; 90th percentile of non-survivors last ICU day: 53,950 pg/ml. b VWF levels increased from day 0 to the last ICU day in survivors (*P = 0.0057, n = 35 pairs) and did not change in non-survivors (P = 0.5070, n = 14 pairs). c Ang-1 levels did not differ between day 0 and the last ICU day in survivors (P = 0.1044, n = 35 pairs) or non-survivors (P = 0.7612, n = 14 pairs)Fig. 3The relation between Ang-2 and VWF levels. Angiopoietin-2 (Ang-2) levels (pg/ml) positively related to von Willebrand factor (VWF) levels (% of reference) at day 0 (filled circle, r = 0.45, P = 0.001, black line). Ang-2 levels throughout the course of septic shock did not relate to VWF levels (open circle day 1, day 2, day 4, day 7, day 14, day 21 and day 28, r = 0.10, P = 0.1190, dotted line)
###end p 29
###begin p 30
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 153 154 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 203 204 203 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 293 304 293 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circle</italic>
###xml 329 342 329 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled circle</italic>
###xml 460 461 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 569 570 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 613 614 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1008 1009 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1084 1085 1084 1085 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1187 1188 1187 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1231 1232 1231 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1301 1302 1301 1302 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1406 1407 1406 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1450 1451 1450 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The course of angiopoietin and VWF levels in survivors and non-survivors. Median and interquartile range of a circulating angiopoietin-2 (Ang-2; pg/ml), b von Willebrand factor (VWF; % of reference) and c angiopoietin-1 (Ang-1) levels (pg/ml) in plasma of intensive care unit (ICU) survivors (open circle) and ICU non-survivors (filled circle) on day 0, 1, 2, 4 and 7. Days 14, 21 and 28 are not shown because of low numbers, but are included in the analysis. a Ang-2 levels tended to be higher in non-survivors than in survivors throughout the course of septic shock (P = 0.199 for survivor vs. non-survivor and P = 0.028 for interaction between day and survivor vs. non-survivor). One non-survivor had extremely high Ang-2 levels: day 0 125,100 pg/ml; day 1 149,000 pg/ml; day 2 114,300 pg/ml; day 4 115,550 pg/ml and day 7 116,800 pg/ml. Therefore, the upper limit of interquartile range at day 7 is 88,263 pg/ml. Analysis without this non-survivor yields a P = 0.039 for survivor versus non-survivor and P = 0.016 for the interaction between day and survivor versus non-survivor. b VWF levels did not differ between survivors and non-survivors throughout the course of septic shock (P = 0.545 for survivor vs. non-survivor and P = 0.218 for interaction between day and survivor vs. non-survivor). c Ang-1 levels did not differ between survivors and non-survivors throughout the course of septic shock (P = 0.189 for survivor vs. non-survivor and P = 0.070 for interaction between day and survivor vs. non-survivor)
###end p 30
###begin p 31
###xml 124 125 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 169 170 169 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 219 220 219 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 458 459 458 459 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 600 601 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 887 888 887 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 956 957 956 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 968 969 968 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1019 1020 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1031 1032 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1046 1047 1046 1047 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1125 1126 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1137 1138 1137 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1169 1170 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1181 1182 1181 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Angiopoietin and VWF levels on day 0 and the last ICU day in survivors and non-survivors. Individual levels and box plot of a circulating angiopoietin-2 (Ang-2; pg/ml), b von Willebrand factor (VWF; % of reference) and c angiopoietin-1 (Ang-1) levels (pg/ml) on day 0 and the last intensive care unit (ICU) day in ICU survivors and ICU non-survivors. Values in boxes are at 25th percentile, median and 75th percentile; whiskers are 10th and 90th percentile. a Ang-2 levels decreased from day 0 to the last ICU day in survivors (*P = 0.0033, n = 35 pairs), while they did not change in non-survivors (P = 0.3910, n = 15 pairs). Data not shown: Day 0 survivor: 25,090 pg/ml; day 0 non-survivor: 17,980 and 125,100 pg/ml; last ICU day non-survivor: 12,050 and 116,800 pg/ml; 90th percentile of non-survivors day 0: 60,828 pg/ml; 90th percentile of non-survivors last ICU day: 53,950 pg/ml. b VWF levels increased from day 0 to the last ICU day in survivors (*P = 0.0057, n = 35 pairs) and did not change in non-survivors (P = 0.5070, n = 14 pairs). c Ang-1 levels did not differ between day 0 and the last ICU day in survivors (P = 0.1044, n = 35 pairs) or non-survivors (P = 0.7612, n = 14 pairs)
###end p 31
###begin p 32
###xml 165 178 165 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled circle</italic>
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 201 211 201 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 295 306 295 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circle</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 384 395 384 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dotted line</italic>
The relation between Ang-2 and VWF levels. Angiopoietin-2 (Ang-2) levels (pg/ml) positively related to von Willebrand factor (VWF) levels (% of reference) at day 0 (filled circle, r = 0.45, P = 0.001, black line). Ang-2 levels throughout the course of septic shock did not relate to VWF levels (open circle day 1, day 2, day 4, day 7, day 14, day 21 and day 28, r = 0.10, P = 0.1190, dotted line)
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 230 238 <span type="species:ncbi:9606">patients</span>
This study demonstrates that circulating Ang-2 positively relates to the fluid balance, pulmonary dysfunction and mortality throughout the course of septic shock. This is in line with the suggested mediator role of Ang-2 in those patients. In contrast, VWF was not positively related to the fluid balance and pulmonary dysfunction and predicted mortality only at the day of ICU admission, suggesting that VWF plays a marker role only in the early phase of septic shock. Indeed, circulating VWF and Ang-2 were related at day 0, but not throughout the course of septic shock.
###end p 34
###begin p 35
###xml 19 20 19 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 22 24 22 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 26 28 26 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 860 861 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 862 863 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 68 75 <span type="species:ncbi:9606">patient</span>
###xml 707 715 <span type="species:ncbi:9606">patients</span>
###xml 1021 1029 <span type="species:ncbi:9606">patients</span>
###xml 1126 1134 <span type="species:ncbi:9606">patients</span>
Experimental data [5, 19, 23] together with several observations in patient studies [4-9, 11, 12, 25] suggest that Ang-2 is a mediator in the pathogenesis of pulmonary vascular permeability and injury. This hypothesis is reinforced by several aspects of the present study. First, the relation between circulating Ang-2 and the fluid balance or pulmonary dysfunction persisted throughout the course of septic shock. Second, this longitudinal relation was Ang-2-specific, since VWF, which is also considered a marker of endothelial activation and dysfunction, did not reflect a positive fluid balance and pulmonary dysfunction. Third, the relation was observed within a relatively homogeneous group of septic patients with high Ang-2 levels and severe vascular permeability and pulmonary dysfunction, while previous studies focused on heterogeneous populations [4-7, 10-12]. In those heterogeneous populations, Ang-2, vascular permeability and pulmonary dysfunction may be related due to a group effect, because non-septic patients have low Ang-2 levels and moderate vascular permeability or pulmonary dysfunction, while septic patients have high Ang-2 levels and severe vascular permeability or pulmonary dysfunction. Nevertheless, in vivo Ang-2 blocking studies are necessary to formally confirm the mediator role of Ang-2.
###end p 35
###begin p 36
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 543 544 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 546 548 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 579 581 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1014 1015 1012 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 1620 1622 1618 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1624 1626 1622 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
###xml 624 632 <span type="species:ncbi:9606">patients</span>
###xml 871 878 <span type="species:ncbi:9606">patient</span>
###xml 988 995 <span type="species:ncbi:9606">patient</span>
###xml 1522 1530 <span type="species:ncbi:9606">patients</span>
Ang-2 levels at day 0 and throughout the course had independent predictive value for 28 day survival, in accordance with a previous study [10], since patients with Ang-2 levels <3,066 pg/ml had longer survival duration than patients with Ang-2 levels >/=3,066 pg/ml, independent of the APACHE II score. Nevertheless, these cutoff values were selected post-hoc and should be validated prospectively. It has been proposed previously that circulating Ang-2 levels may better predict mortality of critically ill patients than the APACHE II score [7, 11]. For instance, Siner et al. [11] reported that there were no deaths among patients with Ang-2 levels less than 10,000 pg/ml, despite a predicted mortality of 16% based on the median APACHE II score. Indeed, the combination of Ang-2 and the APACHE II score had more predictive value than the APACHE II score alone. In our patient group, we did not observe a sharp increase in Ang-2 levels towards the day of death as was described for one patient by Parikh et al. [5]. Ang-2 was continuously higher in non-survivors compared to survivors. Interestingly, Ang-2 levels in survivors, which were already lower throughout the course, decreased from day 0 to the last ICU day. In this light, Ang-2 levels above a certain threshold may mediate the development of endothelial activation and dysfunction, associated with pulmonary dysfunction and mortality. Surprisingly, Ang-1 levels also positively related to pulmonary dysfunction. Nevertheless, Ang-1 levels in our septic shock patients were still much lower than Ang-1 levels in healthy controls according to the literature [10, 12], suggesting that the low Ang-1 levels did not offset the effects of high Ang-2 levels. Indeed, the Ang-2/Ang-1 ratio did not relate to the fluid balance or pulmonary dysfunction and mortality (data not shown).
###end p 36
###begin p 37
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
VWF levels related inversely to the fluid balance and positively to the pulmonary compliance throughout the course of septic shock. This finding is in accordance with studies that did not find a predictive value for the development of ALI/ARDS [33, 34], while other studies reported that VWF levels at the onset of critical illness predicted the development of ALI/ARDS and related to pulmonary permeability [12, 35]. It is unclear how these differences can be explained, but the predictive value of VWF might depend on the time at which the samples were taken during the course of sepsis or ALI/ARDS. Indeed, VWF had predictive value for mortality early in the course of sepsis and ALI/ARDS (day 0), as reported by most [15, 16, 33, 35], but not all prior studies [36], but lost its predictive value on the subsequent days. Although VWF may thus have an important early prognostic role, the data do not suggest a direct pathogenetic role of the factor, in contrast to Ang-2.
###end p 37
###begin p 38
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 818 826 <span type="species:ncbi:9606">patients</span>
In our study, increased Ang-2 and VWF levels were related on day 0 as reported before [8, 12], suggesting that they were released together from the endothelial Weibel-Palade body, but not on the subsequent days. There are several explanations for the observed loss of relation between Ang-2 and VWF levels. First, the synthesis and subsequent storage of Ang-2 and VWF in de Weibel-Palade bodies may become differently regulated throughout the course of disease, so that the ratio between Ang-2 and VWF changed. Second, Ang-2 may not only be released from the Weibel-Palade body, but also by constitutive secretion from the cytoplasm. Indeed, Ang-2 is uniformly distributed in the cytoplasm of endothelial cells in the absence of VWF [13]. Third, the binding or consumption of VWF may be increased in more severely ill patients, for example, during diffuse intravascular coagulation.
###end p 38
###begin p 39
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1293 1294 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1294 1295 1294 1295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 1296 1297 1296 1297 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1298 1299 1298 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1299 1300 1299 1300 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1301 1302 1301 1302 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1438 1440 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1442 1444 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 1989 1990 1989 1990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1990 1991 1990 1991 <sub xmlns:xlink="http://www.w3.org/1999/xlink">a</sub>
###xml 1992 1993 1992 1993 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1994 1995 1994 1995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1995 1996 1995 1996 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1997 1998 1997 1998 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2197 2205 <span type="species:ncbi:9606">patients</span>
Our study has several limitations. First, the relation between Ang-2 and a positive fluid balance or pulmonary dysfunction was relatively modest (r = 0.25-0.30), suggesting that the positive fluid balance and pulmonary dysfunction are only partly due to increased Ang-2 levels. Indeed, it has been reported that Ang-2 sensitizes the endothelium to inflammatory stimuli rather than acting alone in the vascular system [37]. Second, it was not feasible to measure the pulmonary vascular permeability in a more direct manner with the pulmonary leak index method as we did in our previous study [12]. Instead, we studied the relation with fluid balance as surrogate indicator of vascular permeability. The data suggest that differences and changes in fluid balance were not confounded by differences and changes in renal function as can be judged, albeit imperfectly, from serum creatinine levels. Therefore, changes in the fluid balance are likely explained, at least in part, by changes in vascular permeability, even though not reflecting pulmonary vascular permeability directly. However, it is likely that the systemic and pulmonary vascular endothelium are simultaneously activated, since both are exposed to circulating inflammatory mediators. Furthermore, the fluid balance related to the PaO2/FiO2 ratio and the oxygenation index, and we confirmed that a positive fluid balance is related to a worse outcome in ALI and septic shock [26, 27], suggesting that a positive fluid balance includes pulmonary injury-induced oedema. Third, the plasma levels of Ang-2, VWF and Ang-1 and the difference in Ang-2 levels between survivors and non-survivors may have been underestimated due to fluid resuscitation and plasma dilution. This indicates that the difference in plasma levels of the measured proteins may be even greater and the relation with the fluid balance and pulmonary dysfunction even stronger. Fourth, in multivariate analysis, APACHE II score and Ang-2, but not fluid balance, PaO2/FiO2 ratio, oxygenation index, PEEP and Ang-1 at day 0 remained significantly predictive factors of ICU mortality. Nevertheless, the value of this analysis is limited in our relatively small group of 50 patients.
###end p 39
###begin p 40
In conclusion, in contrast to VWF levels, increased Ang-2 levels relate to a positive fluid balance and pulmonary dysfunction throughout the course of septic shock. While VWF levels only predict ICU mortality early in the course of septic shock, Ang-2 levels do so throughout the course. Pharmacological blockade of Ang-2 during the course of septic shock might reduce the degree of vascular permeability and pulmonary dysfunction and should be pursued in future studies for outcome benefits.
###end p 40
###begin title 41
Electronic supplementary material
###end title 41
###begin p 42
Below is the link to the electronic supplementary material.
###end p 42
###begin p 43
Supplementary material 1 (DOC 137 kb)
###end p 43
###begin p 44
We thank Jan van Bezu BSc., VU University Medical Centre, Amsterdam, The Netherlands, for excellent technical assistance. GpvNA was supported by The Netherlands Heart Foundation (The Hague, grant 2003T032). MvdH was supported by the European Society of Intensive Care Medicine (ECCRN Levi Montalcini Biomedical Sciences Award 2007). The funding sources had no involvement in the study design, the collection, analysis and interpretation of data, the writing of the report or the decision to submit the paper for publication.
###end p 44
###begin p 45
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 45
###begin title 46
References
###end title 46
###begin article-title 47
The pathophysiology and treatment of sepsis
###end article-title 47
###begin article-title 48
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
###end article-title 48
###begin article-title 49
Vascular pharmacology of acute lung injury and acute respiratory distress syndrome
###end article-title 49
###begin article-title 50
Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators
###end article-title 50
###begin article-title 51
###xml 89 95 <span type="species:ncbi:9606">humans</span>
Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans
###end article-title 51
###begin article-title 52
###xml 33 41 <span type="species:ncbi:9606">children</span>
Admission angiopoietin levels in children with septic shock
###end article-title 52
###begin article-title 53
Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome
###end article-title 53
###begin article-title 54
Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma?
###end article-title 54
###begin article-title 55
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 79 86 <span type="species:ncbi:9606">patient</span>
Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity
###end article-title 55
###begin article-title 56
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients
###end article-title 56
###begin article-title 57
Elevated serum angiopoietin-2 levels are associated with increased mortality in sepsis
###end article-title 57
###begin article-title 58
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients
###end article-title 58
###begin article-title 59
The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies
###end article-title 59
###begin article-title 60
Dynamics and plasticity of Weibel-Palade bodies in endothelial cells
###end article-title 60
###begin article-title 61
###xml 74 82 <span type="species:ncbi:9606">patients</span>
von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury
###end article-title 61
###begin article-title 62
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury
###end article-title 62
###begin article-title 63
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
###end article-title 63
###begin article-title 64
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
###end article-title 64
###begin article-title 65
The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism
###end article-title 65
###begin article-title 66
Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo
###end article-title 66
###begin article-title 67
Cell-based angiopoietin-1 gene therapy for acute lung injury
###end article-title 67
###begin article-title 68
Protective role of angiopoietin-1 in endotoxic shock
###end article-title 68
###begin article-title 69
Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death
###end article-title 69
###begin article-title 70
The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury
###end article-title 70
###begin article-title 71
###xml 41 49 <span type="species:ncbi:9606">children</span>
Plasma angiopoietin-2 levels increase in children following cardiopulmonary bypass
###end article-title 71
###begin article-title 72
High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury
###end article-title 72
###begin article-title 73
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Negative fluid balance predicts survival in patients with septic shock: a retrospective pilot study
###end article-title 73
###begin article-title 74
###xml 73 78 <span type="species:ncbi:9606">human</span>
Vascular endothelial growth factor is increased during the first 48 h of human septic shock and correlates with vascular permeability
###end article-title 74
###begin article-title 75
Predictors of mortality in acute lung injury during the era of lung protective ventilation
###end article-title 75
###begin article-title 76
Statistical evaluation of ventilator-free days as an efficacy measure in clinical trails of treatments for acute respiratory distress syndrome
###end article-title 76
###begin article-title 77
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
###end article-title 77
###begin article-title 78
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection
###end article-title 78
###begin article-title 79
von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome
###end article-title 79
###begin article-title 80
Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome
###end article-title 80
###begin article-title 81
Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis
###end article-title 81
###begin article-title 82
Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation
###end article-title 82
###begin p 83
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 83
###begin p 84
The online version of this article (doi:10.1007/s00134-009-1560-y) contains supplementary material, which is available to authorized users.
###end p 84

